DRC e Hiperpara.pdf

To address CKD, with emphasis on one of its main complications, SHPT, and the main strategies for its control. Method: Integrative review, using the following databases: PubMed, Latin American Literature in Health Sciences (LILACS), Google Scholar and Scientific Electronic Library Online (SciELO). In the languages: English and Portuguese, in the period between 2020 and 2025 of publication. After searching the scientific literature, seven studies were selected for analysis. Results: A total of 645 articles were identified in the selected databases, of which, after screening by inclusion criteria, exclusion of duplicates and full reading, seven studies comprised the final sample. The PRISMA model was used to ensure transparency of the selection, with independent double checking by the reviewers. Data analysis was qualitative, highlighting theoretical contributions on secondary hyperparathyroidism in chronic kidney disease, although with methodological limitations. Conclusion: Management of secondary hyperparathyroidism in chronic kidney disease requires an individualized and multifactorial approach, with emphasis on phosphorus control, vitamin D use, and therapies such as calcimimetics and parathyroidectomy. These interventions help control PTH and reduce complications, requiring close monitoring to balance efficacy and safety.